It’s only natural.

To replace T-cells with natural killer (NK) cells in the next iterative breakthrough for therapeutic chimeric antigen receptors (CAR). This early-phase trial indicates CAR-NK cells can provide equally miraculous responses with virtually none of the expected toxicity. | Liu, N Engl J Med 2020